B. Do you or your funding sources intend to protect under patent or trade 
secret laws either the products or the procedures developed in the pro- 
posed study? If so, what steps will be taken to permit as full ccmmuni- 
cation as possible among investigators and clinicians concerning research 
methods and results? 
III. Requested Documentation 
In addition to responses to the guestions raised in these "Points to 
Consider," please submit the following materials: 
A. Your protocol as approved by your local IRB and IBC. The consent 
form, which must have IRB approval, should be submitted to the NIH only 
on request. 
B. Local IRB and IBC minutes and reccmmendations that pertain to your 
protocol . 
C. A one-page scientific abstract of the gene therapy protocol. 
D. A one-page description of the proposed experiment in nontechnical language. 
E. Curricula vitae for professional personnel. 
F. An indication of other federal agencies to which the protocol is 
being submitted for review. 
G. Any other material which you believe will aid in the review. 
[ 66 ] 
Recombinant DNA Research, Volume 1 1 
